Call Options Transactions Made in Q2 2023 in Royalty Pharma PLC (RPRX)
This table provides information about the institutional ownership of Royalty Pharma PLC (RPRX) during Q2 2023. The information is specifically focused on institutions that hold call options of Royalty Pharma plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
BUY
|
CALL |
100KNew |
$2.96M - $3.66M
|
100K
$2.43M
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
CALL |
60KNew |
$1.78M - $2.19M
|
60K
$1.46M
|
|
|
Aug 11, 2023
Q2 2023
|
Peak6 Investments LLC
Chicago, IL |
SELL
|
CALL |
-16K- 63.75% |
$474K - $585K
|
9.1K
$221K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-19.6K- 23.82% |
$580K - $717K
|
62.7K
$1.52M
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-127K- 39.89% |
$3.76M - $4.65M
|
192K
$4.65M
|